EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Blood Glucose Response after Betamethasone Injection in Pregnant Women without Diabetes

Pankaj Prakash Salvi, Vidya Ajit Gaikwad, Rushikesh Anil Phutane

Annals of African Medicine · 2026

DOI: 10.4103/aam.aam_372_25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Pankaj Prakash Salvi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra,…. Hauptthemen laut MEDLINE: Betamethasone, Blood Glucose, Glucocorticoids, Hyperglycemia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Betamethasone is routinely administered in preterm pregnancies to accelerate fetal lung maturity, yet its glycemic impact on nondiabetic pregnant women remains underexplored.

Objective

This study aimed to evaluate the effect of betamethasone on maternal glucose levels and hormonal profiles in pregnant women without diabetes and assess the need for monitoring and intervention. Materials and Methods: A prospective observational study was conducted on 80 normoglycemic pregnant women between 24 and 34 weeks of gestation. Each participant underwent an Oral glucose tolerance test and hormonal profiling before and after receiving the first intramuscular dose of injection betamethasone 12 mg. The second dose of injection Betamethasone 12 mg was given 24 h later.

Results

Significant elevations in fasting, 1-h, and 2-h blood glucose levels were observed postbetamethasone ( P < 0.001), along with increased insulin, C-peptide, and cortisol levels, indicating a steroid-induced metabolic shift. Hyperglycemia peaked within 12–24 h. Elevated body mass index and borderline glycated hemoglobin were associated with greater glucose excursions.

Conclusion

Even a single course of betamethasone can induce clinically significant hyperglycemia in nondiabetic pregnant women. Routine poststeroid glucose monitoring is essential to minimize maternal and neonatal risks while preserving the established benefits of antenatal corticosteroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetamethasoneBlood GlucoseGlucocorticoidsHyperglycemiaHumansFemalePregnancyAdultProspective StudiesGlucose Tolerance TestInjections, IntramuscularInsulinGlycated HemoglobinC-PeptideYoung AdultHydrocortisoneBody Mass Index

Stichwörter der Autor:innen

Betamethasone injectionInjection de bétaméthasonefemmes enceintespregnant womenprospective observational studyétude observationnelle prospective

Substanzen

BetamethasoneBlood GlucoseGlucocorticoidsInsulinGlycated HemoglobinC-PeptideHydrocortisone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.

Zitieren

APA

Salvi, P. P., Gaikwad, V. A., & Phutane, R. A. (2026). Blood Glucose Response after Betamethasone Injection in Pregnant Women without Diabetes. Annals of African Medicine. https://doi.org/10.4103/aam.aam_372_25

Vancouver

Salvi PP, Gaikwad VA, Phutane RA. Blood Glucose Response after Betamethasone Injection in Pregnant Women without Diabetes. Annals of African Medicine. 2026. doi:10.4103/aam.aam_372_25

BibTeX
@article{Salvi2026,
  author = {Salvi, Pankaj Prakash and Gaikwad, Vidya Ajit and Phutane, Rushikesh Anil},
  title = {Blood Glucose Response after Betamethasone Injection in Pregnant Women without Diabetes},
  journal = {Annals of African Medicine},
  year = {2026},
  doi = {10.4103/aam.aam_372_25}
}
Kostenlos starten →